The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older AdultsEmily G. McDonald, Todd C. Lee, Allison Goodwin Wilson et al.|JAMA Internal Medicine|2022Cited by 142
Risk stratification schemes, anticoagulation use and outcomes: the risk–treatment paradox in patients with newly diagnosed non-valvular atrial fibrillationRoopinder K. Sandhu, Finlay A. McAlister|Heart|2011Cited by 79
Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, CanadaFinlay A. McAlister|BMJ Open|2018Cited by 36
The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and OntarioFinlay A. McAlister, Douglas S. Lee, Yuan Dong et al.|Canadian Medical Association Journal|2022Cited by 21
Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based StudyCynthia Wu, Finlay A. McAlister|PLoS ONE|2015Cited by 14